Catalyst Funds Management Pty »

Alto Neuroscience shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $256k 11k 22.48

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Alto Neuroscience

Falcon Edge Capital
Commodore Capital
Vestal Point Capital
Perceptive Advisors
Vanguard Group
Vanguard Capital Management
Franklin Resources
Vivo Capital
Armistice Capital
Millennium Management
72 Investment Holdings
BlackRock
Ikarian Capital
Point72 Asset Management
VR Adviser

View all funds holding Alto Neuroscience